Photo via Flickr user Gage Skidmore
Despite growing popular and legislative support for federal cannabis reform, U.S. lawmakers have differing views on whether Congress will can any progress on pot in the near future, says a new report from the Las Vegas Review-Journal. At last week’s annual Marijuana Business Conference and Expo in Las Vegas, Reps. Dana Rohrabacher (R-CA) and Dina Titus (D-NV) joined cannabis lobbyists Michael J. Correia of the National Cannabis Industry Association and Michael Liszewski of The Enact Group on a panel to discuss the current state of federal cannabis policy.
“We were gaining momentum,” Titus said, referencing the Obama administration’s hands-off policy towards state-legal cannabis. But now that the Trump administration has taken power, “that’s flipped and we’re more on the defensive,” she qualified. For the past several years, a federal budget rider known as the Rohrabacher-Farr amendment has prohibited the Justice Department from spending federal funds to prosecute any medical cannabis business or patient complying with state law. “That’s the only thing holding (Sessions) back,” said Liszewski.
This amendment is set…